Treace Medical Concepts logo

Treace Medical ConceptsNASDAQ: TMCI

Profile

Sector:

Healthcare

Country:

United States

IPO:

23 April 2021

Next earnings report:

27 February 2025

Last dividends:

N/A

Next dividends:

N/A
$485.92 M
-72%vs. 3y high
66%vs. sector
-vs. 3y high
-vs. sector
-82%vs. 3y high
79%vs. sector
-80%vs. 3y high
42%vs. sector

Price

regular market | 1 min ago
$7.80+$0.08(+1.02%)

Dividend

No data over the past 3 years
$45.09 M$66.93 M
$45.09 M-$15.36 M

Analysts recommendations

Institutional Ownership

TMCI Latest News

The Schall Law Firm Encourages Shareholders To Take Part In An Inquiry Into Treace Medical Concepts Inc For Securities Law Violations
accesswire.com20 November 2024 Sentiment: -

LOS ANGELES, CA / ACCESSWIRE / November 20, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Treace Medical Concepts, Inc. Is Being Investigated For Fraud And Investors With Losses Are Invited To Contact The Schall Law Firm
accesswire.com19 November 2024 Sentiment: NEGATIVE

LOS ANGELES, CA / ACCESSWIRE / November 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Treace Announces Participation at Stifel 2024 Healthcare Conference
globenewswire.com18 November 2024 Sentiment: POSITIVE

PONTE VEDRA, Fla., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship Lapiplasty ®  and Adductoplasty ®  Procedures, today announced that John T. Treace, Chief Executive Officer, and Mark L. Hair, Chief Financial Officer, will participate in a fireside chat at the Stifel 2024 Healthcare Conference on Tuesday, November 19, 2024, beginning at approximately 8:00 am ET.

Treace Medical Concepts, Inc. Is Being Investigated For Defrauding The Public And Affected Investors Are Urged To Contact The Schall Law Firm
accesswire.com17 November 2024 Sentiment: NEGATIVE

LOS ANGELES, CA / ACCESSWIRE / November 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

The Schall Law Firm Wants Shareholders To Join An Inquiry Into Treace Medical Concepts Inc For Violating Securities Regulations
accesswire.com16 November 2024 Sentiment: NEGATIVE

LOS ANGELES, CA / ACCESSWIRE / November 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

The Schall Law Firm Invites Shareholder Participation In An Inquiry Into Treace Medical Concepts, Inc. For Securities Law Violations
accesswire.com15 November 2024 Sentiment: NEGATIVE

LOS ANGELES, CA / ACCESSWIRE / November 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

The Schall Law Firm Invites Shareholders To Join An Inquiry Into Treace Medical Concepts, Inc. For Securities Law Violations
accesswire.com13 November 2024 Sentiment: NEGATIVE

LOS ANGELES, CA / ACCESSWIRE / November 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

TMCI Investors Have Opportunity to Join Treace Medical Concepts, Inc. Fraud Investigation with the Schall Law Firm
prnewswire.com12 November 2024 Sentiment: NEGATIVE

LOS ANGELES , Nov. 12, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ: TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Treace Medical Concepts Inc Is Being Investigated For Fraud And Affected Investors Are Encouraged To Contact The Schall Law Firm
accesswire.com12 November 2024 Sentiment: NEGATIVE

LOS ANGELES, CA / ACCESSWIRE / November 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

The Schall Law Firm Wants Shareholders To Join An Inquiry Into Treace Medical Concepts, Inc. For Securities Law Violations
accesswire.com11 November 2024 Sentiment: NEGATIVE

LOS ANGELES, CA / ACCESSWIRE / November 11, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

What type of business is Treace Medical Concepts?

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.

What sector is Treace Medical Concepts in?

Treace Medical Concepts is in the Healthcare sector

What industry is Treace Medical Concepts in?

Treace Medical Concepts is in the Medical Devices industry

What country is Treace Medical Concepts from?

Treace Medical Concepts is headquartered in United States

When did Treace Medical Concepts go public?

Treace Medical Concepts initial public offering (IPO) was on 23 April 2021

What is Treace Medical Concepts website?

https://www.treace.com

Is Treace Medical Concepts in the S&P 500?

No, Treace Medical Concepts is not included in the S&P 500 index

Is Treace Medical Concepts in the NASDAQ 100?

No, Treace Medical Concepts is not included in the NASDAQ 100 index

Is Treace Medical Concepts in the Dow Jones?

No, Treace Medical Concepts is not included in the Dow Jones index

When was Treace Medical Concepts the previous earnings report?

No data

When does Treace Medical Concepts earnings report?

The next expected earnings date for Treace Medical Concepts is 27 February 2025